Knowledge of therapy for acute uncomplicated tracheobronchitis among senior students of a medical institute
- Authors: Ukhova E.1
-
Affiliations:
- Mari State University
- Issue: Vol 14 (2025): Материалы XXI Международного Бурденковского научного конгресса 24-26 апреля 2025
- Pages: 568-570
- Section: Клиническая фармакология и фармакоэкономика
- URL: https://new.vestnik-surgery.com/index.php/2415-7805/article/view/10371
Cite item
Full Text
Abstract
In the era of antibiotic resistance, some physicians still unnecessarily prescribe antibacterial therapy to patients. One such example is the administration of antimicrobial agents to individuals suffering from acute uncomplicated tracheobronchitis. Aim. To assess the knowledge of students concerning the use of antibacterial medications for the treatment of upper respiratory tract infections. Materials and methods. Using the technique of anonymous surveys and descriptive statistics, we analyzed the knowledge of senior medical students regarding the management of acute uncomplicated tracheobronchitis. This investigation was carried out as part of the multicenter project KANT (full title — Physicians' (Students') Knowledge in Antimicrobials Usage), which evaluates the understanding of antibiotic therapy among practicing physicians and medical school students. Results. During this work, it became evident that students had limited awareness about the appropriate treatment of acute uncomplicated tracheobronchitis. Numerous students persist in believing that this condition should be managed using antibiotics. Conclusion. Based on our findings, there is a clear need to place greater emphasis on etiological therapies for infectious diseases within the therapeutic training cycles for medical students.
Keywords: antibacterial therapy; tracheobronchitis; antibiotic resistance; etiological therapy; upper respiratory tract infections
Full Text
Introduction. In recent times, it is not uncommon to witness unjustified prescriptions of antibiotics for treating upper respiratory tract infections. This issue requires special attention during the training of future medical professionals.
Objective. The aim of this study was to assess the level of knowledge among senior medical students regarding the treatment of acute uncomplicated tracheobronchitis using anonymous questionnaire-based surveys.
Materials and Methods. This work was conducted as part of the fifth stage of the multicenter project KANT (full title — Physicians' (students') knowledge in antimicrobials usage). The project began in 2012, with several stages already completed 1-3. In this study, we present the results of a voluntary anonymous survey involving 176 medical students from Yoshkar-Ola, Ufa, Belgorod, Nukus, and Krasnoyarsk between 2023 and 2025. Each participant received a questionnaire consisting of ten questions related to antimicrobial therapy based on clinical guidelines. We analyzed the eighth question, where students were asked to indicate their choice of first-line drug for treating acute uncomplicated tracheobronchitis. Among the options provided were: no antibiotic required, ampicillin, amoxicillin, amoxicillin/clavulanic acid, cefazolin, ceftriaxone, cefixime, macrolides (azithromycin, clarithromycin, josamycin), doxycycline, norfloxacin, ciprofloxacin, levofloxacin and moxifloxacin, gentamicin, furazidin and nitrofurantoin, fosfomycin, or "I don't know." Descriptive statistical methods were used for analysis.
Results. The correct answer ("no antibiotic required") was chosen by 105 students (59.7%). A significant number of respondents selected penicillins: 38 individuals (21.6%) chose amoxicillin, 32 (18.2%) opted for ampicillin, and 22 (12.5%) preferred amoxicillin/clavulanic acid. Other students selected various other antibacterial agents: cefazolin — 12 people (6.8%), ceftriaxone — 13 (7.4%), cefixime — 12 (6.8%), macrolides — 13 (7.4%), doxycycline — 11 (6.25%), norfloxacin — 7 (3.9%), ciprofloxacin — 10 (5.7%), levofloxacin and moxifloxacin — 8 (4.55%), gentamicin — 6 (3.4%), furazidin and nitrofurantoin — 5 (2.8%), and fosfomycin — 9 (5.1%).
Figure 1 shows the distribution of antibiotic choices made by students for treating acute uncomplicated tracheobronchitis.
Conclusion. The findings of this analysis revealed that some students lack knowledge about the appropriate treatment for acute uncomplicated tracheobronchitis. The author attributes this deficiency to potential gaps in understanding the etiology of the disease. Therefore, it is recommended to place greater emphasis on teaching etiotropic therapies for infectious diseases within therapeutic disciplines and clinical pharmacology courses for medical students.
About the authors
Emiliya Ukhova
Mari State University
Author for correspondence.
Email: kuznetsova.emiliya@list.ru
ORCID iD: 0009-0008-0288-589X
A specialist at the Medical Research and Educational Center, an assistant professor at the Department of Physiology and Pathology of the Medical Institute of Mari State University
Russian Federation, 424000, Russia, Republic of Mari El, Yoshkar-Ola, Lenin Square, 1References
- Bontsevich RA, Kirienko JA, Bogatova VE, Miliutina EV, Kovalenko VS, Melnichenko AA, Batishcheva GA, Goncharova NY, Agapov AV (2018) Assessment of senior medical care majors’ knowledge in antimicrobial chemotherapy. Research Results in Pharmacology 4(4): 107–113. https://doi.org/10.3897/rrpharmacology.4.31960
- Бонцевич Р.А., Адонина А.В., Гаврилова А.А., Батищева Г.А., Черенкова О.В., Гончарова Н.Ю., Биккинина Г.М., Барышева В.О., Кетова Г.Г., Бочанова Е.Н., Даулетбеков Н.Д., Тилекеева У.М. Оценка уровня знаний студентов старших курсов медицинских вузов по вопросам рационального применения антимикробных препаратов в клинической практике: результаты проекта «KANT». Клиническая микробиология и антимикробная химиотерапия. 2020; 22(3):212-220. doi: 10.36488/cmac.2020.3.212-220
- Бонцевич Р.А., Тихойванова А.А., Анненков Н.В., Батищева Г.А., Невзорова В.А., Мартыненко И.М., Биккинина Г.М., Кетова Г.Г., Барышева В.О., Лучинина Е.В. Определение знаний студентов старших курсов медицинских вузов по антимикробной терапии (итоги проекта KANT-IV). Клиническая микробиология и антимикробная химиотерапия. 2024; 26(1): 87-97. doi: 10.36488/cmac.2024.1.87-97
Supplementary files
There are no supplementary files to display.
